{"id":593100,"date":"2022-03-25T20:20:03","date_gmt":"2022-03-25T20:20:03","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=593100"},"modified":"2022-03-25T20:20:03","modified_gmt":"2022-03-25T20:20:03","slug":"neuromodulation-market-worth-88-billion-by-2025-key-players-are-medtronic-ireland-boston-scientific-corporation-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/neuromodulation-market-worth-88-billion-by-2025-key-players-are-medtronic-ireland-boston-scientific-corporation-us_593100.html","title":{"rendered":"Neuromodulation Market Worth $8.8 Billion by 2025 – Key Players are Medtronic (Ireland), Boston Scientific Corporation (US)"},"content":{"rendered":"
\n
\"Neuromodulation<\/a><\/div>\n
\n
The prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel)<\/div>\n<\/div>\n<\/div>\n
Neuromodulation Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.<\/div>\n

According to the new market research report “Neuromodulation Market<\/a> by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) – Global Forecast to 2025″<\/strong>, published by MarketsandMarkets™, the Neuromodulation Market is projected to grow at a CAGR of 8.6% during the forecast period to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020.<\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=921<\/a><\/p>\n

The Factors such as the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders are driving market growth. <\/strong><\/p>\n

The internal neuromodulation segment accounted for the largest share of the Neuromodulation Market.<\/strong><\/p>\n

Based on technology, the neuromodulation is segmented into internal neuromodulation and external neuromodulation. The internal neuromodulation segment accounted for the largest share of the market in 2019. This can be attributed to the benefits of internal neuromodulation technologies, such as reductions in post-surgical complications and length of hospital stay, as well as long-term cost savings associated with the use of internal neuromodulation devices.<\/p>\n

Browse in-depth TOC on<\/em> “<\/strong>Neuromodulation Market“<\/strong><\/p>\n

177 – Tables<\/strong>
25 – Figures<\/strong>
156 – Pages<\/strong><\/strong><\/p>\n

The transcutaneous electrical nerve stimulation segment accounted for the largest share of the External Neuromodulation Market in 2019.<\/strong><\/p>\n

Based on type, the External Neuromodulation Market is segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). TENS accounted for the largest share of this market in 2019. This is mainly due to the higher incidence of chronic disorders, the wide range of applications of these devices, their cost-effectiveness, and the rising demand for non-invasive therapy.<\/p>\n

Request Sample Report: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=921<\/a><\/p>\n

North America to dominate the Neuromodulation Market during the forecast period<\/strong><\/p>\n

In 2019, North America dominated the market, followed by Europe. The major factors driving the growth of this market include the rising prevalence of chronic diseases, the increasing geriatric population, and the rising number of cases of Lyme and Alzheimer’s disease.<\/p>\n

The prominent players in this market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), and LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/neurostimulation-devices-market-921.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel) Neuromodulation Market Research Report Gives … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,417,404],"tags":[],"class_list":["post-593100","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Marketing-Sales","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/593100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=593100"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/593100\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=593100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=593100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=593100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}